EYPTEyePoint, Inc.
$3.40-74% 1Y
$3.40
$3.1552 weeks$18.85
The financials
EyePoint, Inc. by the numbers
EyePoint, Inc. (EYPT) reported revenue of $507K in Q2 2026 (quarter ended Jun 30, 2026), down 90% from the same quarter a year earlier. That came with net loss of $94M. For the full year FY2025, revenue was $31M (−28% year on year) and net income −$232M. Its largest product in Q1 2026 (quarter ended Mar 31, 2026) was Royalty at $141K, 62% of the disclosed total, well ahead of License And Collaboration Agreement at 38%. The next results filing is expected around Nov 4, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $507K | $5.3M | −90% |
| Operating income | −$97M | −$62M | n/a |
| Net income | −$94M | −$59M | n/a |
| Diluted EPS | −$1.09 | −$0.85 | n/a |
| Product | Revenue | Share |
|---|---|---|
| Royalty | $141K | 62% |
| License And Collaboration Agreement | $88K | 38% |
Business segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Jun 2026Total $507.0K (+121%)
License And Collaboration Agreement grew -90% year on yearProduct Rights Agreement -100% year on year
Segment Latestquarter on quarteryear on year
- License And Collaboration Agreement$507.0K$507.0Kquarter on quarter +476%year on year -90%+476%-90%
- Product Rights Agreement$0.00$0.00quarter on quarter n/ayear on year -100%n/a-100%
- Royalty$0.00$0.00quarter on quarter -100%year on year n/a-100%n/a
On our screens:Most shorted stocks